Noor Imran 

Professor Williams 

Writing of the Sciences

19 November 2021

The Human Papillomavirus (HPV) is the most prevalent sexually transmitted illness that affects both men and women. Cervical and penile carcinomas, vulvar, vaginal, anal, oropharyngeal malignancies, and precancers, such as genital warts, are all linked to the HPV virus. Merck & Co. produced the HPV vaccination, which was approved for use in June of 2006. While there is substantial debate over HPV vaccination, including practical and ethical concerns, immunizations are necessary to prevent many coming-of-age teenagers and adults from life-threatening infections, especially when they begin sexual activity at a younger age. The importance of an HPV vaccine is that as generations abstinence is not practiced as much as past generations. Many people, especially people of color, are afraid of vaccines. Since the vaccine was recently approved in 2006, many people are still hesitant over it. 

There are an estimated 15 million instances of sexually transmitted illnesses in the United States alone, including two infections: trichomoniasis and human papillomavirus. According to the literature, there are more than 150 documented HPV viruses,  with about 40 examples of sexual transmission. HPV strains 16 and 18 are now responsible for 70 percent of cervical malignancies in Europe (Munoz, 2003). Munoz also collected data from 9 distinct women, all from various nations, in 1918, with microscopically studied squamous-cell cervical cancer and a 1928 control group of women in a research. A personal interview/questionnaire was used to get information on the risk variables. After that, cervical cancer cells were extracted for HPV/DNA testing. According to the final data, 90.7 percent in 259 of the 1928 control group of women had cervical cancer. The infections induced by these viruses can be devastating, resulting in significant morbidity and, in the worst-case scenario, death. Physicians and scientists are now able to spot it early because of technological advancements. For example, more than a decade after the first HPV vaccine was licensed, two effective vaccinations targeting oncogenic HPV viral subtypes have been available. As a consequence of the vaccination, 20,000 people have avoided becoming cervical cancer patients since domestic sales of HPV vaccinations began. 

Schools in the United States have mandatory vaccination programs, resulting in an increase in the total number of students who get vaccinated. Many children from low-income families do not have complete access to these three prescribed dosages within the six-month period. These youngsters, however, can be vaccinated because of connection to Medicaid or other state-sponsored insurance programs. Male genital sores, penile cancer, and other tumors have all been found to spread the vaccination to both sexes in previous research. Furthermore, a decrease in male lesions acquired from female sexual partners has been recorded, owing to the fact that they are vaccinated.

The purpose of this research is to emphasize the importance of the human papillomavirus (HPV) vaccine. The concept of HPV vaccination has always been a contentious study. Scientists have collected data, conducted experiments, and challenged opposing viewpoints throughout history and now. As scientists continue to demonstrate how the HPV vaccine saves many people from life-threatening infections, they argue that the issue of HPV is a human rights issue, not merely an ethical one.